- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Imatinib Mesylate
Total 1351 results
-
Renato MelaragnoUnknownChronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+)Brazil
-
Asan Medical CenterCompleted
-
Renato MelaragnoSuspendedAcute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)
-
Technical University of MunichCompleted
-
Duke UniversityNovartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the SkinUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Dermatofibrosarcoma Protuberans | Adult FibrosarcomaUnited States
-
NovartisCompletedLeukemiaUnited States
-
National Cancer Institute (NCI)CompletedGastrointestinal Stromal TumorUnited States
-
Annick DesjardinsNovartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
National Cancer Institute (NCI)CompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Accelerated Phase Chronic Myelogenous Leukemia | Childhood Chronic Myelogenous Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic... and other conditionsUnited States
-
SCRI Development Innovations, LLCNovartisCompletedSolid Tumors | Refractory MalignancyUnited States
-
Peking University Cancer Hospital & InstituteUnknown
-
SCRI Development Innovations, LLCNovartis; Genentech, Inc.CompletedClear Cell Renal Cell Carcinoma
-
National Cancer Institute (NCI)CompletedRelapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedAccelerated Phase Chronic Myelogenous Leukemia | Childhood Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Duke UniversityNational Cancer Institute (NCI); Novartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
NovartisCompleted
-
National Cancer Institute (NCI)CompletedChildhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
National Cancer Institute (NCI)TerminatedTesticular Seminoma | Recurrent Ovarian Germ Cell Tumor | Stage II Ovarian Germ Cell Tumor | Stage III Ovarian Germ Cell Tumor | Ovarian Dysgerminoma | Recurrent Malignant Testicular Germ Cell Tumor | Stage II Malignant Testicular Germ Cell Tumor | Stage III Malignant Testicular Germ Cell TumorUnited States
-
National Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Malignant NeoplasmUnited States
-
University of CologneSanofi; Novartis; Roche Pharma AGCompleted
-
AstraZenecaCompleted
-
NovartisNational Cancer Institute (NCI)Completed
-
Deric M Park MDUnknown
-
Annick DesjardinsAstraZeneca; Novartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
NYU Langone HealthNovartisTerminatedOvarian CancerUnited States
-
Chong Kun Dang PharmaceuticalCompletedGastrointestinal Stromal Tumors | Chronic Myeloid LeukemiaKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Royal Marsden NHS Foundation TrustCompletedAdvanced Pancreatic CancerUnited Kingdom
-
European Organisation for Research and Treatment...CompletedSarcoma | Small Intestine Cancer | Ovarian Cancer | Endometrial Cancer | Gastrointestinal Stromal TumorFrance, Denmark, Netherlands, Belgium, United Kingdom
-
European Organisation for Research and Treatment...CompletedSarcomaFrance, Belgium, Netherlands, United Kingdom
-
European Organisation for Research and Treatment...Terminated
-
Agenus Inc.TerminatedLeukemia, Myeloid, ChronicUnited States, United Kingdom
-
Poitiers University HospitalNovartisCompletedChronic Myeloid LeukemiaFrance
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedPhase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaLeiomyosarcoma | Fibrosarcoma | Liposarcoma | Malignant Fibrous HistiocytomaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsJapan
-
University of KansasNovartis; Kansas Masonic Cancer Research InstituteCompleted
-
M.D. Anderson Cancer CenterBreakThrough TherapeuticsCompletedChronic Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedHead and Neck Cancer | Squamous Cell CancerUnited States
-
Novartis PharmaceuticalsTerminatedMalignant Peripheral Nerve Sheath TumorsGermany